Page 32 - BH-3-1
P. 32

Brain & Heart                                                                Cardioneuroablation for VMB



            CNA techniques and has paved the way for more refined   right superior GP and targeting all left atrial GPs. Further
            and patient-specific procedures. Aksu et al. 13,18,22,24,26,34,40,46,47    research is required to determine whether focusing solely
            employed a streamlined approach targeting primary GPs   on the right superior GP provides long-term benefits and
            in the atria, which yielded positive outcomes. Conversely,   to further elucidate the complex regulation of GPs. CNA is
            Zhao  et  al.  and Qin  et  al.  conducted anatomical GP   a novel surgical technique that currently lacks long-term
                     12
                                   16
            ablations in both atria to manage symptomatic sinus   clinical follow-up data extending beyond a decade. While
            bradycardia. Debruyne  et al. 19,25  adopted a unifocal   the growing body of short-term evidence is promising,
            approach on the right side to address neurally mediated   long-term studies are essential to evaluate the durability
            syncope and sinus node issues. In the two case reports   of its outcomes. Moreover, its prolonged effects remain to
            presented in this study, we demonstrate that CNA can   be determined. The long-term success of this procedure
            achieve favorable outcomes whether the approach is from   can be undermined by incomplete ablation, potentially
            the RA or LA. This efficacy is likely due to the anatomical   resulting in reinnervation due to the presence of remaining
            position of the RAGP, which is located between the LA   intramural parasympathetic post-ganglionic neurons. To
            and RA, allowing access to this GP site from either atrium   address this issue, future approaches could involve multiple
            (Figure 7).                                        ablations using both endocardial and epicardial pathways
                                                               to improve long-term outcomes.
              The interaction among GPs necessitates careful selection
            of targeted GPs for ablation to minimize potential adverse   In clinical practice, we encounter two primary patient
            effects.  Chiou  et al.   identified a  fat  pad  near the right   populations. The first group includes those with VMB who
                            48
            pulmonary artery as a critical relay point in the cardiac   may avoid the need for pacemaker implantation through
            autonomic network, which Debruyne  et al. 19,25  targeted   CNA. The second group consists of a significant cohort
            during their procedures. By systematically selecting which   of patients who had previously received a pacemaker due
                                                                      28
            GPs to target based on patient-specific anatomical and   to VMB.  For these patients, CNA has the potential to
            functional markers, the risk of unnecessary complications   render both the pacemaker and its implanted electrodes,
            can be reduced, and outcomes can be optimized. Our   which may degrade over time, unnecessary. The broader
            prior research on CNA in patients with vasovagal syncope   clinical implications of this procedure include reducing
            demonstrated  that  sequentially  targeting  specific  GPs,   dependency on long-term device management, which
            starting from the left superior GP to the RAGP, resulted   could potentially ease the burden on healthcare systems
            in  immediate  and  sustained  heart  rate  increases  during   while improving patients’ quality of life. This paradigm
            ablation of the RAGP, with other GPs primarily eliciting   shift could reshape how clinicians manage VMB patients
            vagal responses. 21,49  This suggests that the RAGP plays a   in the coming years.
            significant role in CNA outcomes. Despite these findings,   Our analysis included studies with relatively small
            there is a direct comparison between ablating only the   sample sizes or retrospective designs. Future investigations
                                                               should aim to include extensive, prospective, multicenter
                                                               studies that are double-blinded and randomized to further
                                                               validate  our  conclusions. A  recent search of  the  https://
                                                               clinicaltrials.gov/website  revealed  numerous  prospective
                                                               clinical trials designed to evaluate the effects of CNA
                                                               on VMB. 50,51  In addition, randomized controlled trials
                                                               have been performed to compare the outcomes of CNA
                                                               with pacemaker implantation.  We look forward to the
                                                                                        52
                                                               forthcoming results of these studies with great interest.
                                                               These investigations are expected to address existing gaps
                                                               in knowledge, providing the robust evidence required to
                                                               establish clinical practice guidelines.
                                                                 Despite its promising outlook, several challenges
                                                               remain  to  be addressed.  First,  the complexity  of  the
                                                               cardiac autonomic nervous system necessitates a nuanced
            Figure 7. The three-dimensional endocardial surface of the left atrium   understanding of GP interactions and precise techniques to
            and right atrium and locations of the right anterior ganglionated plexus.   ensure successful outcomes. The lack of universal protocols
            The right anterior ganglionated plexus (within the red dashed circle) is
            located between the left and right atria, allowing access to it from either   for GP targeting leads to variability in procedural efficacy. In
            atrium.                                            addition, cost considerations and the availability of trained


            Volume 3 Issue 1 (2025)                         7                                doi: 10.36922/bh.4824
   27   28   29   30   31   32   33   34   35   36   37